Compare

Lemaitre Vascular Inc vs Orthopediatrics Corp vs Treace Medical Concepts, Inc. vs SkinHealth Systems Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Lemaitre Vascular Inc LMAT	Orthopediatrics Corp KIDS	Treace Medical Concepts, Inc. TMCI	SkinHealth Systems Inc. SKIN
Year ended	2025-12-31	2025-12-31	2025-12-31	2025-12-31
Revenue	$249.60M	$236.35M	$212.69M	$300.79M
Revenue growth (YoY)	+13.5%	+15.4%	+1.6%	-10.0%
Gross margin	71.5%	73.1%	79.8%	65.3%
Operating margin	27.2%	-16.6%	-25.5%	-6.9%
Net margin	23.1%	-16.8%	-27.7%	-3.2%
Net income	$57.73M	-$39.65M	-$59.00M	-$9.52M
EPS (Diluted)	$2.52	-$1.69	-$0.93	-$0.16
Operating cash flow	$81.25M	-$4.85M	-$15.97M	$37.48M
Free cash flow	$74.47M	-$15.96M	-$29.49M	$37.18M
Cash & equivalents	$28.24M	$19.56M	$10.71M	n/a
Total assets	$615.69M	$508.63M	$190.58M	$499.80M
Total liabilities	$222.17M	$162.03M	$103.25M	$438.75M
Shareholders' equity	$393.52M	$346.60M	$87.33M	$61.06M
Return on year-end equity	14.7%	-11.4%	-67.6%	-15.6%
Shares outstanding	22.77M	25.09M	n/a	127.52M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Lemaitre Vascular Inc	Orthopediatrics Corp	Treace Medical Concepts, Inc.	SkinHealth Systems Inc.
Latest	$249.60M Ended 2025-12-31	$236.35M Ended 2025-12-31	$212.69M Ended 2025-12-31	$300.79M Ended 2025-12-31
1 year earlier	$219.86M Ended 2024-12-31	$204.73M Ended 2024-12-31	$209.36M Ended 2024-12-31	$334.29M Ended 2024-12-31
2 years earlier	$193.48M Ended 2023-12-31	$148.73M Ended 2023-12-31	$187.12M Ended 2023-12-31	$397.99M Ended 2023-12-31
3 years earlier	$161.65M Ended 2022-12-31	$122.29M Ended 2022-12-31	$141.84M Ended 2022-12-31	$365.88M Ended 2022-12-31
4 years earlier	$154.42M Ended 2021-12-31	$98.05M Ended 2021-12-31	$94.42M Ended 2021-12-31	$260.09M Ended 2021-12-31